Nulojix is prescribed to kidney transplant patients to prevent rejection in transplant patients that have been exposed to Epstein-Barr virus.
Nulojix is an immunosuppressant that suppresses the activity of T-cells which may be involved in organ rejection.
Nulojix works by binding to two molecules CD80 and CD86 that are responsible for activating and stimulating T-cells. By preventing the activation of T-Cells, Nulojix helps prevent organ donor rejection.
Initial dosing schedule: day of transplant and then 4 days, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.
Every 4 weeks after the initial dose.
What to Expect During Your Infusion
Before your infusion, it is important to drink plenty of water and come to your appointment hydrated. Additionally, you must alert us as soon as possible to any changes in your insurance to ensure that we are still an in-network provider for your infusion therapy.
Your dedicated Infusion nurse will check your vitals and review your medical history to check for improvements or potential side effects of your infusion therapy.
Your nurse will begin your infusion and check in on you periodically during your treatment.
After your infusion, your nurse will monitor you for 30 minutes to ensure you do not have any complications or reactions to the infusion therapy.
Why patients choose Pure to receive their Nulojix infusion
At Pure Infusion Suites®, we create an unmatched patient experience, improve healthcare outcomes and lower the cost of care.
Safe & Private Suites
Comfortable, private rooms with a relaxing, spa-like atmosphere
55” TVs with Netflix, Wifi, drinks, snacks, meals & more